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Abstract
Background: The study aimed to quantify changes of the optic nerve head (ONH) during exposure to high altitude and to
assess a correlation with acute mountain sickness (AMS). This work is related to the Tuebingen High Altitude
Ophthalmology (THAO) study.
Methodology/Principal Findings: A confocal scanning laser ophthalmoscope (cSLO, Heidelberg Retina Tomograph, HRT3H)
was used to quantify changes at the ONH in 18 healthy participants before, during and after rapid ascent to high altitude
(4559 m). Slitlamp biomicroscopy was used for clinical optic disc evaluation; AMS was assessed with Lake Louise (LL)and AMS-
cerebral (AMS-c) scores; oxygen saturation (SpO2) and heart rate (HR) were monitored. These parameters were used to
correlate with changes at the ONH. After the first night spent at high altitude, incidence of AMS was 55% and presence of
clinical optic disc edema(ODE) 79%. Key stereometric parameters of the HRT3H used to describe ODE (mean retinal nerve fiber
layer [RNFL] thickness, RNFLcross sectionalarea, optic discrimvolumeandmaximum contour elevation) changed significantly
at high altitude compared to baseline (p,0.05) and were consistent with clinically described ODE. All changes were reversible
in all participants after descent. There was no significant correlation between parameters of ODE and AMS, SpO2 or HR.
Conclusions/Significance: Exposure to high altitude leads to reversible ODE in the majority of healthy subjects. However,
these changes did not correlate with AMS or basic physiologic parameters such as SpO2 and HR. For the first time, a
quantitative approach has been used to assess these changes during acute, non-acclimatized high altitude exposure. In
conclusion, ODE presents a reaction of the body to high altitude exposure unrelated to AMS.
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Introduction
Swelling of the optic nerve head (or optic disc edema, ODE) at
high altitude was first described in 1969 in Indian soldiers
stationed between 3300–5500 m above sea level [1]. In this study,
most affected soldiers also presented with signs of high altitude
cerebral edema (HACE) such as severe headache, stupor, coma,
and increased intra-cranial pressure (ICP). Optic disc edema has
since been reported by several other authors in mountaineers with
HACE [2,3] and in case reports where it was found in conjunction
with high altitude retinopathy, a clinical entity of hemorrhages and
other retinal alterations [4,5,6,7,8]. In 3 out of 21 climbers who
had ascended to altitudes above 7500 m Wiedmann and Tabin
described persistent ODE [9]. The most recent study by Bosch
et al. funduscopically reported ODE in climbers at very high
altitude [10]. Moreover, they described a positive and statistically
significant correlation of their findings with AMS.
The term AMS describes an altitude-related potentially
life threatening condition with headache as the main clinical
characteristic [11]. Associated vegetative symptoms include nausea,
insomnia, anorexia and dizziness. Although generally benign, AMS
can progress to HACE, which is life threatening if left untreated
[12]. Underlying mechanisms of AMS are still under debate with
some research groups favoring cerebral edema of varying degree as
the underlying mechanism for all forms of the disease [13]. In
addition, indirect evidence suggests brain edema as a possible cause
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e27022of AMS [14,15]. However, another study measuring intracranial
pressure by lumbar puncture during hypoxia exposure was not able
to detect significant differences in subjects with or without AMS
[16]. Thus pathophysiology of AMS remains a conundrum.
Examination of the optic nerve head in the posterior segment of
the eye provides a unique possibility to directly and non-invasively
visualize the state of the cranial nerve. Causes for alterations of the
optic nerve head can be manifold and may point to various
underlying diseases and pathophysiologic mechanisms, including
toxic, inflammatory and infectious diseases, compression, ischemia
and alsoto high ICPdueto increased cerebro-spinal fluid volume or
cerebral edema [17]. A positive correlation of AMS and ODE may
therefore support a causative role of high ICPin patients with AMS.
This study was undertaken to objectively quantify optic disc
morphology using state of the art technology by using confocal
scanning laser ophthalmoscopy (cSLO) in addition to stereoscopic
slit-lamp funduscopy in a defined setting in volunteers exposed to
high altitude at the Capanna Margherita (4559 m, Italy). AMS
was assessed by clinical questionnaires and correlation between
quantitatively measured ODE and AMS was tested.
Methods
Study design
In this prospective field study 18 participants ascended to the
Capanna Margherita (CM; Valais Alps, Italy) accompanied by a
mountain guide according to the following ascent profile (Figure 1):
day0 from Gressoney (Italy) 1635 m to Punta Indren 3260 m by
cable car followed by 2 hours (hrs) of hiking to the Capanna
Gnifetti 3647 m; day1 ascent to the CM 4559 m in 4–6 hrs. All
participants ascended within 24 hrs from Gressoney to the CM.
Fourteen participants spent 3 nights (from day1 to day4) and 4
participants (investigators) 12 nights at the CM before descending
back to Gressoney in one day. Prior to baseline recordings
(BL1=before and BL2=after the expedition) and high altitude
exposure, subjects had to spend .14 days below 2000 m and were
not allowed to climb above until the start of the research
expedition. Included were healthy, physically fit participants (7
females and 11 males; age 25–54 years, mean=3568 (SD) years)
capable of climbing to the CM within 24 hrs from Gressoney.
General exclusion criteria were any type of cardiac or respiratory
disease. None of the participants had a history of HACE or high
altitude pulmonary edema (HAPE). Only non-steroidal anti-
inflammatory agents were allowed and administered after consul-
tation of a study group physician. Ophthalmological exclusion
criteria were refractive error greater than 65 diopters spherical
equivalent, astigmatism more than 62 diopters, presence of disor-
ders affecting the optic disc, or optical opacities limiting imaging
quality. Due to set-up procedures of the equipment at high altitude
14 participants were measured on day1, 16 participants on day2
and day3 and all 18 participants on day4. The 4 participants, who
spent 13 days at high altitude, were measured regularly over time.
The study was performed in accordance with the tenets of the
Declaration of Helsinki 1975 (1983 revision) and was approved by
the local IRB (Ethik-Kommission der Medizinischen Fakulta ¨t und
am Universita ¨tsklinikum Tuebingen, IEC project number: 258/
2010B01). All participants gave written informed consent after
having been informed of the nature of the research expedition.
Clinical assessment of Acute Mountain Sickness and vital
parameters
For assessment of AMS the Lake-Louise (LL) and the AMS-
cerebral score (AMS-c) of the Environmental Symptom Question-
naire (ESQ III) were used once at BL1 and BL2, and twice daily
during altitude exposure [18,19]. All subjects were thoroughly
informed regarding the nature of the questionnaires prior to
baseline recordings. The same study staff was involved at all time
points and was available for help in completing the questionnaires
on as-needed basis. AMS was assumed when both scores met the
cut-off criteria set for LL $5 in the presence of a headache and
AMS-c $0.70 as described previously [16]. Measurements of
oxygen saturation and HR were performed once at BL1 and BL2,
at high altitude in the morning before getting up and in the
evening after .5 minutes rest with a finger pulse oximeter (oxy
control 4cH, Geratherm Medical AG, Geschwenda, Germany).
Values were recorded after one minute of steady measurement.
Blood hemoglobin content (Hb) and hematocrit were measured
from samples drawn from an antecubital vein through the
University Hospital’s laboratory at BL1 and BL2. At high altitude
whole blood was again drawn from an antecubital vein and
collected in EDTA containing tubes (Monovette, Sarstedt,
Nu ¨mbrecht, Germany) for measurements of Hb using an Hb-
miniphotometerH (Dr. Bruno Lange GmbH, Berlin, Germany)
and for measurements of hematocrit following a centrifugation at
6 min of 13 0006g (micro-hematocrit centrifuge, Hettich, Tut-
tlingen, Germany) on day1, day2, and day4 at high altitude.
Slit lamp biomicroscopy and quantitative analysis of
optic nerve head
All participants underwent general ophthalmological examina-
tion including best corrected visual acuity and slit lamp stereo
biomicroscopy of the anterior and posterior segment. According to
Figure 1. Ascent profile to the Capanna Margherita (4559 m). Ascent profile of participants to the Capanna Margherita (4559 m). Numbers
indicate the four HRT3H measurements performed at high altitude.
doi:10.1371/journal.pone.0027022.g001
Optic Disc Edema at High Altitude
PLoS ONE | www.plosone.org 2 November 2011 | Volume 6 | Issue 11 | e27022the criteria for detecting ODE described by Walsh and Hoyt, the
right and left optic discs were judged by the same experienced
ophthalmologist either as swollen, not swollen or equivocal once at
BL1 and BL2, and daily during high altitude exposure [20] using a
LED-powered slit lamp (BQ900H, Haag-Streit International,
Koeniz, Switzerland) with non-contact wide field and high mag
lenses (Digital Wide FieldH and Digital High MagH, Volk Optical
Inc., Mentor, OH, USA). All equipment was transported by
helicopter (Air Zermatt AG Heliport, Zermatt, Switzerland) in
airfreight containers provided by the manufacturers.
To quantitatively measure the changes of the ONH two
identical HRT3H (Heidelberg Engineering, Heidelberg, Germany)
devices were used for baseline measurements and for measure-
ments at altitude [21]. To exclude systemic error and ensure
comparability of measurements, we exported the raw data from
baseline recordings and imported it before follow-up measure-
ments at altitude took place to correct for errors such as tilt and
orientation. Calibration of HRT3H devices was performed before
each measurement according to instructions by the manufacturer
to ensure comparability of measurements. Details of the
instrument and its reproducibility have been published elsewhere
[22,23,24]. Briefly, it features a 670-nm light source in a confocal
optic pathway that acquires topographic images as a series of 32
two-dimensional transverse optic sections (each 2566256 pixels),
acquired in ca. 1.5 seconds. To correct for magnification errors,
patients’s keratometry readings were considered by the software.
Each recording consisted of the mean of three consecutive scans;
measurements were performed at baseline once before (BL1), daily
during and once again after exposure (BL2) to high altitude on
both eyes. After the first measurement at BL1 an optic disc
contour line was drawn manually along the inner margin of the
peripapillary scleral ring by the same experienced operator. All
consecutive measurements were automatically corrected for
orientation/tilt and fitted according to the baseline measurement
to allow optimal follow-up calculation. The built-in HRT software
version 2.01 calculated the stereometric parameters of the optic
nerve head. For evaluation of changes at the ONH, all
stereometric parameters from all measurements of both eyes were
exported for statistical analysis as tab-delimited text files. As
measurements of the left and right eye revealed no significant
differences (see results section), only the right eye was considered.
The following 12 stereometric parameters were used for further
statistical analysis: mean RNFL thickness, rim area, RNFL cross
sectional area, rim volume, average variability, cup area, cup
volume, disc area, maximum contour elevation, maximum cup
depth, mean cup depth, and vertical cup/disk ratio. They were
selected for their potential to detect ODE and to test general
validity of the recordings. To assess a potential correlation of ODE
with AMS, the following stereometric parameters were correlated
with AMS-c, LL, SpO2, HR, and age: rim volume, mean RNFL
thickness, RNFL cross sectional area and maximum contour
elevation; all quantitative measurements were performed in the
morning and recordings of day2 were used for correlation analysis.
Statistical Methods
For statistical analysis JMPH was used (Version 8.0.2, SAS
Institute, Cary, NC). Comparisons were performed by multivar-
iate analysis of variance (MANOVA) for repeated measures. Data
are shown in terms of intra-individual ratios (value during
exposure/value at BL1) and the 95% confidence interval for each
time point. Additional analysis of the data using the paired t-test
for each time point vs. BL1 resulted in equal outcomes. To
evaluate a possible correlation between changes at the ONH and
AMS or basic physiologic parameters the Pearson’s correlation
coefficient between recorded HRT3H values and clinical param-
eters (SpO2, HR, AMS-c, LL and age) was calculated.
Results
All 18 participants reached the CM using the described ascent
profile and completed all planned examinations during 4 days at
high altitude as noted in Figure 1. Incidence of AMS was 61% in
the evening after arrival at the CM on day1, 55% in the morning
of day2 and decreased distinctly thereafter with a tendency for
higher values in the mornings (for details of AMS scores see
Table 1). The maximum LL recorded during our high altitude stay
was 13 on day1; the top AMS-c score was reached in the morning
of day3 with 2.79 in one participant, who had to be treated with
4 mg dexamethasone intravenously on day3 and again orally on
day4 before descent. AMS-c, LL and overall well-being improved
rapidly after initial steroid treatment. Mean LL was highest in the
Table 1. Overview of systemic parameters of THAO study participants.
BL1
day1
evening
day2
morning
day2
evening
day3
morning
day3
evening
day4
morning BL2
LL 0 5.7063.10 5.2262.58 3.8362.04 4.0663.04 2.0661.40 2.2861.90 0
AMS-c 0 1.0560.67 1.1360.75 0.6660.61 0.6560.72 0.2260.30 0.3060.32 0
AMS [%] 0 61 56 28 28 0 11 0
Heart rate (HR) [min
21]6 0 . 3 3 67.22 89.4065.92 82.7369.71 80.06611.72 76.78611.39 75.39613.19 72.22612.73 58.7866.38
SpO2 [%] 98.5061.29 70.6065.18 73.0066.01 74.2866.61 74.2265.62 77.2863.82 79.5665.15 98.5061.25
Hemoglobin (Hb) [g/dL] 14.3261.29 13.6561.10 14.2161.18 N/A N/A N/A 14.9761.09 15.7860.75
Hematocrit (Hct) [%] 42.1763.17 43.1962.37 44.9763.24 N/A N/A N/A 45.2961.98 44.0663.24
n=18; Hb and Hct for 1 evening and 2 morning n=16; values are given as mean6standard deviation; N/A=not applicable.
doi:10.1371/journal.pone.0027022.t001
Table 2. Overview of clinical funduscopic results.
BL1 day1 day2 day3 BL2
swollen 0 9 11 10 0
equivocal 0 2 1 2 0
not swollen 14 3 2 2 14
optic disc edema [%] 0 64 79 64 0
n=14.
doi:10.1371/journal.pone.0027022.t002
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PLoS ONE | www.plosone.org 3 November 2011 | Volume 6 | Issue 11 | e27022Figure 2. Automated Track Change Analysis (TCA) of the optic nerve head. Automated Track Change Analysis (TCA) of the optic nerve
head shows increase in neuroretinal rim height in a representative participant between baseline recording (BL1, left) and recording at high altitude
(day2, right). The change is color coded with green indicating an increase of tissue (see scale on the right).
doi:10.1371/journal.pone.0027022.g002
Figure 3. Changes of key stereometric parameters at high altitude. Intraindividual changes (expressed as ratios) of key stereometric
parameters at altitude show statistically significant but reversible optic disc edema at high altitude. (A) Mean retinal nerve fiber layer (RNFL) thickness,
(B) rim volume, (C) RNFL cross sectional area and (D) maximum contour elevation are significantly increased between day2 and day4 of altitude
exposure (p,0.05). Individual measurements at baseline prior to the climb (BL1) were normalized to display intraindividual ratios of values at high
altitude/BL1. Blue dashed lines indicate BL1 level; red lines indicate mean; whiskers indicate 95% confidence interval; number of subjects: nday1=14,
nday2–3=16, nday4=18.
doi:10.1371/journal.pone.0027022.g003
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the morning of day2 (1.1360.75). Heart rate was increased in all
participants at high altitude, while oxygen saturation was
expectably decreased; hematocrit and hemoglobin values did not
change significantly during high altitude exposure (see Table 1).
Incidence of ODE as assessed by slit-lamp biomicroscopy was
0% at BL1 and reached 64% on day1 (evening) at the CM;
incidence increased to 79% on day2 and decreased to 64% on
day3 (no slit lamp biomicroscopy was performed on day4 due to
organization of descent). At BL2 all discs had returned to normal
and no ODE was observed. Data are given in Table 2. Optic discs
judged as equivocal were not considered. Interestingly, optic disc
margins were blurred most noticeably on the nasal side of the disc.
Statistical analysis of quantitative stereometric parameters
(HRT3H) confirmed the clinical impression of symmetric ODE
changes with no statistically significant differences between the
right and left eye for BL1, BL2 and any of the high altitude
recordings of day1–4 (data not shown). Therefore, only measure-
ments of right eyes are presented in the following. Quantitative
measurements (HRT3H) before and after high altitude exposure
(BL1 vs. BL2) did not reveal statistically significant differences
(95% confidence interval (CI) ; p.0.50) for all 12 outcome
measures (see methods section and Table S1), indicating complete
reversibility of all changes that had developed during exposure to
high altitude. Specifically, CI and p-values (BL1 vs. BL2) of all key
stereometric parameters were: rim volume (CI for BL1=0.33 to
0.47 and BL2=0.33 to 0.46; p=0.92), mean RNFL thickness (CI
for BL1=0.24 to 0.30 and BL2=0.24 to 0.30; p=0.90), RNFL
cross sectional area (CI for BL1=1.13 to 1.45 and BL2=1.13 to
1.45; p=0.99) and maximum contour elevation (CI for
BL1=20.16 to 20.09 and BL2=20.17 to 20.11; p=0.60).
The complete data set is provided as Table S1. As illustrated in
Figure 2, HRT3H analysis using the automated track change
analysis (TCA) showed an increase in neuroretinal rim height
between BL1 and recording at high altitude (day2). However, six
hrs after arrival at the CM on day1 the increase in RNFL thickness
was not statistically significant, but reached significance in the
morning at day2, 3 and 4 (Figure 3A). An identical pattern was
seen for the ratios of rim volume, RNFL cross sectional area and
maximum contour elevation, that were also significantly higher on
day2, 3 and 4 than at BL1, but not on day1 (Figure 3B–D).
Average variability, maximum and mean cup depth remained
stable overall, but were significantly increased on day1 or on day2
respectively. Cup volume, cup and disk rim areas, and vertical
cup/disk ratio remained unchanged at altitude. Data of all 12
stereometric parameters at high altitude from day1–4 compared to
BL1 recordings are summarized in Table 3.
Pearson’s correlation analysis revealed no statistically significant
correlation between ODE and AMS, when comparing with the
four key stereometric parameters (mean RNFL thickness, RNFL
cross sectional area, rim volume and maximum contour elevation)
that showed significant alteration at altitude with AMS-c, LL,
SpO2 or HR. Ratios of mean RNFL thickness did not correlate
with AMS-c, LL, HR and/or SpO2 as shown in Figure 4A–D.
Neither did ratios of RNFL cross sectional area, maximum
contour elevation and rim volume correlate with AMS-c, LL, HR
and/or SpO2. For detailed overview, complete data set is
presented in Table 4. No correlation was found for ratios of
maximum and mean cup depths, which were significantly
increased on day2 (data not shown). Pearson’s correlation
coefficient was calculated to assess a potential correlation of age
and the 4 key stereometric parameters on day2 using AMS-c and
LL. Both scores correlated significantly with age (AMS-c:
r=20.51; CI=20.79 to 20.06; p=0.03 and LL: r=20.63;
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stereometric parameters correlated with age: mean RNFL
thickness (r=20.09; CI=20.56 to 0.43; p=0.74), RNFL cross
sectional area (r=20.13; CI=20.59 to 0.39; p=0.64), rim
volume (r=20.13; CI=20.59 to 0.39; p=0.63) and maximum
contour elevation (r=20.17; CI=20.61 to 0.36; p=0.53).
Changes at the ONH were also monitored for a longer period of
high altitude exposure in four participants (investigators) who
spent 13 consecutive days at the CM without descending. As
shown in Figure 5, the ratio of mean RNFL thickness, which was
significantly increased in all participants on day2–4 at high altitude
(Figure 3A), showed a comparable increase. Mean ratios remained
elevated at altitude up to day10 before decreasing towards and
almost reaching baseline levels on day11 to day13. RNFL cross
sectional area, rim volume and maximum contour elevation
showed matching trends (data not shown).
Discussion
This study was undertaken to objectively quantify optic disc
changes during high altitude exposure and evaluate them within
the context of previous reports of high altitude-related ODE.
Assessment of the ONH as visible part of the brain is of clinical
importance since changes in morphology may provide further
insight into the pathophysiology of AMS.
Upon high altitude exposure the majority of participants
developed bilateral ODE, i.e. 64% on the day of arrival at CM
and 79% on the next morning as described by slitlamp
biomicroscopy. Significant ODE was detected objectively using
cSLO at high altitude on day2, 3 and 4. No correlation between
ODE and AMS at high altitude was found. All findings completely
resolved after exposure without detectable residuals at low altitude
showing no statistically significant changes between BL1 and BL2,
even in volunteers featuring greatest changes at the ONH or in
those with highest AMS scores. To the best of our knowledge this
is the first study to use state of the art, clinical diagnostic
equipment such as a LED-powered slitlamp and HRT3H for
detailed quantitative evaluation of optic disc changes.
The incidence of ODE determined clinically by stereoscopic slit
lamp biomicroscopy at high altitude was comparable to the data
presented by Bosch et al., despite considerable differences between
ascent protocol, maximum elevation, exposure time and acclima-
tization state [10]. Although highly valuable and indispensible in
clinical practice, stereoscopic slit lamp biomicroscopy has the
disadvantage of being a subjective method for judgment of the
optic disc, unable to deliver objective and quantitative data
[25,26]. Since the introduction of cSLO in the HRT1H,
ophthalmologists are in the position to objectively determine and
quantify ODE, and other alterations of the ONH [27,28]. The
most relevant stereometric parameters for assessing ODE (mean
RNFL thickness, RNFL cross sectional area, rim volume and
maximum contour elevation) were found to increase significantly
during high altitude exposure. Our data indicate the development
of ODE as soon as 6 hrs after arrival at the CM (day1). On day2
and subsequent days 3 and 4, all key stereometric parameters were
significantly increased (p,0.05). In the four participants who
Figure 4. Correlation of optic disc edema with AMS and clinical
parameters during high altitude exposure. Optic disc edema does
not correlate with AMS-c, LL, HR or SpO2. Representative correlation
analyses between mean retinal nerve fiber layer (RNFL) thickness ratios
and (A) AMS-c (r=0.30; CI=20.23 to 0.69; p=0.25), (B) LL (r=0.21;
CI=20.32 to 0.64; p=0.43), (C) heart rate (r=0.06; CI=20.45 to 0.54;
p=0.82) and (D) SpO2 (r=20.31; CI=20.70 to 0.22; p=0.25). Analysis
was performed using data from day2 of high altitude exposure. Crosses
indicate four participants with highest, squares those with lowest RNFL
thickness measurements. Red lines indicate bivariate normal ellipse
(p=0.95); blue lines fit simple regression equations; n=16.
doi:10.1371/journal.pone.0027022.g004
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parameters remained elevated until day10, while AMS-c and LL
scores already started to decrease from day2 and were zero from
day4 onwards.
A vast majority of clinical changes at the ONH consisted of
evident edema with only very few equivocal changes. All discs
judged as edematous would have prompted physicians to order
subsequent testing in otherwise healthy patients. While all
stereometric parameters showed statistically significant changes
supporting the notion of altitude related ODE, absolute changes
ranged from 5–8% (Table 3). The magnitude of changes fits well
with reports of disc swelling in patients with optic neuritis while
studies in arteritic or non-arteritic ischemic optic neuropathy
found larger changes at the ONH [29,30]. All alterations of the
optic disc were completely reversible upon return to low altitude
(Table S1) with no detectable sequels of ODE at BL2 even in
participants who suffered from severe AMS. This makes any
chronic effects unlikely. While long-term observations are needed
to definitively exclude any residual structural and functional
changes, it seems unlikely that acute short-term exposure to an
altitude of 4559 m is able to induce permanent damage to the
optic nerve considering the large number of mountaineers
reaching this or even much higher altitudes with no reported
long term pathology.
As anticipated, our ascent profile induced AMS in roughly 50%
of our participants fitting well with the predicted 30% to 60%
range for this kind of ascent profile depending on individual
susceptibility [31]. To objectively and quantitatively test for a
correlation between ODE and AMS-c, LL, HR, SpO2 or age, we
used HRT3H readings acquired on the first morning at the CM
(day2) because AMS related scores reached peak values at that
time point (Table 1), which is in line with existing literature [12].
On day1, exhaustion would have been suspected to skew clinical
scores and on day3 the AMS related scores already decreased
dramatically, while ODE parameters remained elevated through-
out all days at high altitude (Figure 3). However, the analysis
yielded no significant correlation of key stereometric parameters
with AMS-c or LL. The highest, yet still non-significant cor-
relation was observed for AMS-c vs. rim volume (r=0.43; CI=
20.08 to 0.77; p=0.09) and again for LL vs. rim volume (r=0.30;
CI=20.24 to 0.69; p=0.23). Previous studies have suggested
several other ocular changes under hypoxia and/or high altitude
exposure to correlate with AMS as measured by AMS-c and LL,
among them optic disc swelling, increased optic nerve sheath
diameter, increased corneal thickness and increased retinal
capillary blood flow [10,15,32,33]. In contrast, pupil dynamics
and intra ocular pressure have been found not to correlate with
symptoms of AMS [34,35]. While our data showed no relevant
correlation between ODE and AMS, and ODE and resting HR,
O’Connor et al. have found a correlation between severity of AMS
and HR [36]. Our data supports previous data suggesting a lower
incidence of AMS in older people with a moderate but significant
Table 4. Pearson’s correlation of key stereometric parameters with clinical scores of AMS on day2.
AMS-c LL HR SpO2
Mean RNFL thickness [mm] 0.30; 20.23–0.69; 0.25 0.21; 20.32–0.64; 0.43 0.06; 20.45–0.54; 0.82 20.31; 20.70–0.22; 0.25
Maximum contour elevation [mm] 0.40; 20.12–0.75; 0.12 0.24; 20.29–0.66; 0.36 0.33; 20.20–0.70; 0.22 20.26; 20.67–0.27; 0.33
RNFL cross sectional area [mm
2] 0.32; 20.21–0.71; 0.22 0.23; 20.30–0.65; 0.38 0.03; 20.47–0.52; 0.90 20.29; 20.69–0.24; 0.28
Rim volume [mm
3] 0.43; 20.08–0.76; 0.09 0.29; 20.24–0.69; 0.27 0.03; 20.47–0.52; 0.90 20.22; 20.65–0.31; 0.41
Values are presented in the following order as: r, 95% confidence interval (CI), p-value.
doi:10.1371/journal.pone.0027022.t004
Figure 5. Optic disc edema during long term exposure at high altitude. Optic disc edema (ODE) persists beyond acclimatization. Mean
retinal nerve fiber layer (RNFL) thickness ratios in four participants with extended exposure to altitude at CM (4559 m) indicate elevated ratios for
RNFL thickness up to day12 of exposure. Blue dashed lines indicate BL1 level; red lines indicate mean; nday2, 12–13=2,n day3–7, 9–11=4,n day8=3.
doi:10.1371/journal.pone.0027022.g005
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However, none of the key stereometric HRT3H parameters
correlated significantly with age. Therefore we hypothesize that
AMS may correlate with age, but independently of ODE. Support
against a correlation of ONH changes and AMS can also be
drawn from the independent development of parameters of the
ONH and AMS scores with HRT3H stereometric parameters
remaining elevated at high altitude over 10 days and AMS scores
being 0 from day4 onward (Figure 5).
The pathophysiology of AMS has –despite considerable interest
and research efforts in the last decades– remained a conundrum
and cause of debate in high altitude physiology. It has been
proposed that AMS is a subclinical form of early HACE, sharing a
common pathophysiological background [39]. Extracellular vaso-
genic edema caused by disruption of the blood-brain-barrier (BBB)
leading to raised intracranial pressure and mechanical vascular
leakage has been suggested to play a key role in the development
of severe AMS and HACE [11,40]. However, a study conducted
by Bailey et al. detected no evidence for BBB dysfunction, nor
conclusive evidence for a significantly raised intracranial pressure
with only minimal increase in overall brain volume regardless of
AMS symptoms [16], which is in line with other studies [41,42].
Kallenberg et al. suggested that extracellular vasogenic edema
contributes to generalized brain edema independent of AMS,
while cytotoxic intracellular edema may correlate with AMS [43].
Thus, it has been suggested that mild brain swelling during
sustained periods of hypoxia or high altitude exposure occurs, but
does not correlate with AMS.
Previous studies have consistently confirmed the existence of
ODE at high altitude albeit with differences to as to its incidence.
This might well be due to different ascent profiles or duration of
altitude exposure. This is why we chose a well-established ascent
profile for our study with the primary goal to study ocular changes
in regard to AMS at high altitude [44,45]. One of the major
strengths of our study was the nature of our study design. We used
the research facility of the CM, which provides outstanding
research conditions at high altitude ensuring standardized
procedures. Objective, quantitative outcome measures obtained
by the same experienced investigators using state of the art
equipment were used. By testing for intraindividual differences
over time, each participant acted as its own control solving the
problem of interindividual differences in cross sectional analyses.
This is important as such a field study provides limited possibilities
to increase the number of participants.
Our clinical funduscopic examinations and quantitative
HRT3H values constitute evidence for symmetric bilateral ODE
occurring in the majority of persons exposed to high altitude. As a
mild increase of brain volume during hypoxia exposure indepen-
dent of elevated lumbar pressure has been reported [16], we
speculate that bilateral ODE caused by altitude exposure is not
caused by increased ICP. Thus ODE may not be termed high
altitude related papilledema as this entity is defined by increased
ICP. ODE is also described in disturbed venous outflow when
capillary venous pressure in the retinal, ciliar or combined system
of the ophthalmic artery is increased due to thrombosis, cardiac
insufficiency, etc. [46]. Since increased diameters of retinal veins
have been well described and are a hallmark of high altitude
retinopathy, it seems plausible that this mechanism may be
responsible for the ONH changes observed at high altitude.
Cytotoxic intracellular edema as described for the brain by MRI
studies at normobaric hypoxia [43] may also contribute to ODE as
a result of reduced axonal transport [17,47].
In conclusion our present findings indicate that ODE occurs
during hypoxia exposure at high altitude, may persist over time
despite further acclimatization and is fully reversible after descent
to lower altitudes. However, in contrast to a previous study we did
not find a correlation between AMS and ODE. Therefore, we
suggest that ODE occurs independently of AMS during high
altitude exposure.
Supporting Information
Table S1 Overview of HRT3H readings between BL1
and BL2.
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